Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Oga, Toru ^a   Tsukino, Mitsuhiro ^b   Hajiro, Takashi ^c   Ikeda, Akihiko ^d   Nishimura, Koichi ^e  

^a KYOTO UNIVERSITY   (Japan)

^b Hikone Municipal Hospital   (Japan)

^c TENRI HOSPITAL   (Japan)

^d NISHI KOBE MEDICAL CENTER   (Japan)

^e Takanohara Central Hospital   (Japan)

Author keywords

Airflow limitation; COPD; Diffusing capacity; Disease progression; Dyspnea; Exercise; Psychological status

Indexed keywords

CARBON MONOXIDE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; QUESTIONNAIRE; SCORING SYSTEM; DISEASE COURSE; EXERCISE TEST; LUNG; LUNG DIFFUSION CAPACITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATISTICAL MODEL; TIME; VITAL CAPACITY;

ACTIVITIES OF DAILY LIVING; AGED; DISEASE PROGRESSION; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; LUNG; MALE; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; VITAL CAPACITY;

EID: 84866564568     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-85     Document Type: Article

References (39)

1. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease http://www.goldcopd.com (updated 2011), Global Initiative for Chronic Obstructive Lung Disease.
2. Halpin DMG, Tashkin DP. Defining disease modification in chronic obstructive pulmonary disease. COPD 2009, 6:211-225. 10.1080/15412550902918402, 2699950, 19811377.
3. Mahler DA, Tomlinson D, Olmstead EM, Tosteson ANA, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995, 151:61-65.
4. Lareau SC, Meek PM, Press D, Anholm JD, Roos PJ. Dyspnea in patients with chronic obstructive pulmonary disease: does dyspnea worsen longitudinally in the presence of declining lung function?. Heart Lung 1999, 28:65-73. 10.1016/S0147-9563(99)70044-0, 9915932.
5. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007, 101:146-153. 10.1016/j.rmed.2006.04.001, 16713225.
6. Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res 2010, 11:79. 10.1186/1465-9921-11-79, 2902430, 20565728.
7. McGravin CR, Artvinli M, Naoe H. Dyspnoea, disability, and distance walked: comparison of exercise performance in respiratory disease. BMJ 1978, 2:241-243. 10.1136/bmj.2.6132.241, 1606354, 678885.
8. Brooks SM. Surveillance for respiratory hazards. ATS News 1982, 8:12-16.
9. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758. 10.1378/chest.85.6.751, 6723384.
10. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42:773-778. 10.1136/thx.42.10.773, 460950, 3321537.
11. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
12. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982, 14:377-381.
13. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:1185-1189.
14. Mahler DA. Measurement of dyspnea: clinical ratings. Dyspnea: mechanisms, measurement, and management Vol. 208, 147-165 2005, Boca Raton, FL: Taylor&Francis Group, Mahler DA, O'Donnell DE, Second.
15. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005, 128:62-69. 10.1378/chest.128.1.62, 16002917.
16. Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000, 161:1897-1901.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
18. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Analysis of longitudinal changes in the psychological status of patients with asthma. Respir Med 2007, 101:2133-2138. 10.1016/j.rmed.2007.05.009, 17601721.
19. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Koyama H, Mishima M. Longitudinal changes in patient vs physician-based outcome measures did not significantly correlate in asthma. J Clin Epidemiol 2005, 58:532-539. 10.1016/j.jclinepi.2004.09.012, 15845341.
20. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011, 365:1184-1192. 10.1056/NEJMoa1105482, 21991892.
21. Casanova C, de Torres JP, Aguirre-Jaíme A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med 2011, 184:1015-1021. 10.1164/rccm.201105-0831OC, 21836135.
22. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 185:44-52. 10.1164/rccm.201106-0992OC, 22016444.
23. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with chronic obstructive pulmonary disease. Chest 2002, 121:1434-1440. 10.1378/chest.121.5.1434, 12006425.
24. Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest 2007, 132:1283-1290. 10.1378/chest.07-0703, 17646223.
25. Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD 2005, 2:81-89. 10.1081/COPD-200050651, 17136967.
26. Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med 1991, 85(Suppl B):25-31.
27. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11:122. 2944278, 20831787.
28. Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res 2011, 12:40. 10.1186/1465-9921-12-40, 3090353, 21477298.
29. Jones PW, Donohue JF, Nedelman J, Pascoe S, Pinault G, Lassen C. Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis. Respir Res 2011, 12:161. 10.1186/1465-9921-12-161, 3287973, 22206353.
30. Nishimura K, Yasui M, Nishimura T, Oga T. Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?. Respir Res 2011, 12:135. 10.1186/1465-9921-12-135, 3203060, 21988843.
31. Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011, 183:604-611. 10.1164/rccm.201003-0472OC, 20889909.
32. Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012, 185:918-923. 10.1164/rccm.201105-0939PP, 22246177.
33. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007, 167:60-67. 10.1001/archinte.167.1.60, 17210879.
34. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004, 23:698-702. 10.1183/09031936.04.00121404, 15176682.
35. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186:155-161. 10.1164/rccm.201201-0034OC, 22561964.
36. Oga T, Nishimura K, Tsukino M, Hajiro T, Mishima M. Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD. Respir Med 2006, 100:965-971. 10.1016/j.rmed.2005.10.006, 16298519.
37. Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, Yates JC, Anderson JA, Willits LR, Wise RA. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med 2011, 183:317-322. 10.1164/rccm.201004-0665OC, 20813884.
38. Lopez Varela MV, Montes-de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010, 36:1034-1041. 10.1183/09031936.00165409, 20378599.
39. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. Chest 1998, 113:619-624. 10.1378/chest.113.3.619, 9515834.